- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05651438
Pain, Fatigue and Sleep Quality of E-Athletes
Investigation of Factors Associated With Pain, Fatigue and Sleep Quality in E-Athletes
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Balıkesir
-
Bandırma, Balıkesir, Turkey (Türkiye)
- Melike Sumeyye Ozen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
The inclusion criteria were: (1) being between 18 and 35 years of age, (2) being under contract with a professional gaming corporation, (3) being primarily engaged in esports through a computer-based game, (4) having at least one year of professional gaming experience, and (5) volunteering to participate in the study.
The exclusion criteria were: (1) being retired from esports and (2) having any systemic, orthopedic, or neurological disease.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
E-Athletes
E-Athletes who are over the age of 18, have participated in professional matches for at least one year, and have an E-sports license were evaluated.
|
Assessment of pain, fatigue, sleep quality, physical activity status, and e-sports-specific features
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pittsburgh Sleep Quality Index
Time Frame: baseline
|
It is used to assess sleep quality.
The total score ranges from 0 to 21.
The sleep quality of people with a total score of less than 5 is "good"; For those with more than 5, it means "poor" sleep quality.
|
baseline
|
|
Epworth Sleepiness Scale
Time Frame: baseline
|
It is used to evaluate daytime sleepiness.
The scoring method is the same for all questions, 0 if there is no probability of falling asleep, 1 if there is a low probability of falling asleep, 2 if there is a medium probability, and 3 if there is a high probability of falling asleep.
A score of 10 or more indicates the presence of excessive daytime sleepiness.
|
baseline
|
|
Pain assessment
Time Frame: baseline
|
The area where the pain is experienced, the situation of applying to a health institution for pain, the situation of applying to a physiotherapist for pain, and pain severity (with the Numerical Rating Scale (NRS) will be questioned.
NRS: The number 0 is defined as "no pain" and the number 10 as "unbearable pain".
|
baseline
|
|
Fatigue severity
Time Frame: baseline
|
Fatigue severity will be evaluated using the Numerical Rating Scale (NRS), where 0 will indicate "no fatigue" and 10 will indicate "worst possible fatigue."
Participants will report the degree of fatigue they will have felt during the past 24 hours, reflecting their overall daily experience.
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic variables
Time Frame: baseline
|
Age, gender
|
baseline
|
|
Esports-related characteristics
Time Frame: baseline
|
duration of professional gaming, daily computer use, game branch, place of competition, and game type
|
baseline
|
|
Physical activity status
Time Frame: baseline
|
will be classified as active if they engage in ≥150 min/week
|
baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Mental Disorders
- Sleep Wake Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Pain
- Fatigue
- Sleep Initiation and Maintenance Disorders
- Investigative Techniques
- Therapeutics
- Behavior Control
- Immobilization
- Restraint, Physical
Other Study ID Numbers
- 2022-84
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.